{
  "type": "ref",
  "text": "Modulating metastasis by a lymphangiogenic switch in prostate cancer.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "metastasis",
        "a lymphangiogenic switch",
        "prostate cancer"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the main cause of cancer?",
          "What is the mechanism that modifies metastasis in prostate cancer?",
          "What is the most common type of cancer that can be treated with a lymphangiogenic"
        ]
      }
    }
  },
  "asked": {
    "What is the effect of a nuclear hormone receptor on cancer cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0006208419799804688,
        "ground_truth": {
          "metastasis": {
            "bertscore": 0.7011741995811462,
            "f1": 0
          }
        }
      }
    },
    "What is the mechanism that causes metastasis?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lymphangiogenic switch",
        "answerability": 0.6084587574005127,
        "ground_truth": {
          "a nuclear hormone receptor": {
            "bertscore": 0.690665066242218,
            "f1": 0
          }
        }
      }
    }
  }
}